Company intelligence / Profile preview

SEP Acquisition

Ownership: Public · SEPA
Development stage: Preclinical

Overview

SEP Acquisition Corp was a publicly traded special purpose acquisition company focused on merging with or acquiring businesses in the healthcare and life sciences sector. In August 2023, it entered into a definitive merger agreement with SANUWAVE Health, an FDA-approved wound care products provider. The combined entity is expected to focus on advanced wound care using directed energy technologies and will be listed on Nasdaq under the symbol "SNWV".

Industry: Investors

Partnerships

Sweat Equity Partners LPMercury Life Sciences

Financials

Market cap: $59.4M
Enterprise value: $59.4M

Beyond the preview

Go deeper on SEP Acquisition.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEP Acquisition.

Explore the full profile